Abstract:Background: Adverse drug reactions (ADRs) refer to an unintended harmful reaction that occurs after the administration of a medication for therapeutic purposes, which is unrelated to the intended pharmacological action of the drug. In the United States, ADRs account for 6% of all hospital admissions annually. The cost of ADR-related illnesses in 2016 was estimated at USD 528.4 billion. Increasing the awareness of ADRs is an effective measure to prevent them. Assessing suspected drugs in adverse events helps to enhance the awareness of ADRs. Methods: In this study, a suspect drug assisted judgment model (SDAJM) is designed to identify suspected drugs in adverse events. This framework utilizes the graph isomorphism network (GIN) and an attention mechanism to extract features based on patients' demographic information, drug information, and ADR information. Results: By comparing it with other models, the results of various tests show that this model performs well in predicting the suspected drugs in adverse reaction events. ADR signal detection was conducted on a group of cardiovascular system drugs, and case analyses were performed on two classic drugs, Mexiletine and Captopril, as well as on two classic antithyroid drugs. The results indicate that the model can accomplish the task of predicting drug ADRs. Validation using benchmark datasets from ten drug discovery domains shows that the model is applicable to classification tasks on the Tox21 and SIDER datasets. Conclusions: This study applies deep learning methods to construct the SDAJM model for three purposes: (1) identifying drugs suspected to cause adverse drug events (ADEs), (2) predicting the ADRs of drugs, and (3) other drug discovery tasks. The results indicate that this method can offer new directions for research in the field of ADRs.

Data Mining and Analytical Models to Predict and Identify Adverse Drug-drug Interactions

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

Comprehensive Review of Drug-Drug Interaction Prediction Based on Machine Learning: Current Status, Challenges, and Opportunities

Drug–drug interaction prediction: databases, web servers and computational models

Application of Artificial Intelligence in Drug–Drug Interactions Prediction: A Review

A Novel Deep Learning Model for Drug-drug Interactions

Computerized techniques pave the way for drug-drug interaction prediction and interpretation

MLRDA: A Multi-Task Semi-Supervised Learning Framework for Drug-Drug Interaction Prediction

Analysis and prediction of drug–drug interaction by minimum redundancy maximum relevance and incremental feature selection

Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

Abstract 4923: A systematic framework for predicting adverse drug reaction signals using medical data

Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes

BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs

Deep Learning Prediction of Adverse Drug Reactions Using Open TG-GATEs and FAERS Databases

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms

Deep learning for drug‐drug interaction prediction: A comprehensive review

A Survey on Computational Approaches to Predicting Adverse Drug Reactions.

A Comprehensive Review of Computational Methods for Drug-drug Interaction Detection

Propensity score‐adjusted three‐component mixture model for drug‐drug interaction data mining in FDA Adverse Event Reporting System

Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports

Identification of Drug-Drug Interactions Using Chemical Interactions